PCIG vs. XPH ETF Comparison
Comparison of Polen Capital International Growth ETF (PCIG) to SPDR S&P Pharmaceuticals ETF (XPH)
PCIG
Polen Capital International Growth ETF
PCIG Description
PCIG aims to deliver sustainable, above-average earnings growth and long-term stock price appreciation within the global ex-US equity market. The strategy is rooted in fundamental research, selecting 25-35 large-cap growth companies with a sustainable edge like consistent earnings growth, robust balance sheets, and shareholder-oriented management teams. Such companies are selected within industries characterized by high barriers to entry, such as those requiring substantial capital investment, government approvals, or significant intellectual property. Moreover, it integrates ESG factors into the investment process. While the fund may concentrate investments in the consumer discretionary and financial sectors, it avoids over-concentration in any one industry. Investments are typically held for the long term but are subject to period review and potential sale based on changing market conditions, company performance, or perceived threats to competitive advantage.
Grade (RS Rating)
Last Trade
$9.46
Average Daily Volume
5,619
10
XPH
SPDR S&P Pharmaceuticals ETF
XPH Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.Grade (RS Rating)
Last Trade
$46.34
Average Daily Volume
60,002
44
Performance
| Period | PCIG | XPH |
|---|---|---|
| 30 Days | -2.52% | -0.77% |
| 60 Days | -4.25% | 3.73% |
| 90 Days | -4.83% | 5.39% |
| 12 Months | 28.11% |
0 Overlapping Holdings
| Symbol | Grade | Weight in PCIG | Weight in XPH | Overlap |
|---|
PCIG Underweight 44 Positions Relative to XPH
| Symbol | Grade | Weight | |
|---|---|---|---|
| CORT | B | -4.96% | |
| LBPH | A | -4.12% | |
| BMY | B | -4.11% | |
| ITCI | C | -4.01% | |
| JAZZ | B | -3.94% | |
| VTRS | A | -3.73% | |
| AXSM | B | -3.59% | |
| EWTX | C | -3.42% | |
| CTLT | C | -3.41% | |
| ELAN | D | -3.35% | |
| PRGO | C | -3.35% | |
| RPRX | D | -3.18% | |
| JNJ | C | -3.17% | |
| ZTS | D | -3.15% | |
| PFE | F | -3.07% | |
| LLY | F | -2.94% | |
| MRK | D | -2.93% | |
| TARS | C | -2.81% | |
| OGN | F | -2.58% | |
| SAVA | C | -2.57% | |
| ARVN | F | -2.53% | |
| PBH | A | -2.5% | |
| SUPN | C | -2.15% | |
| AMPH | F | -2.02% | |
| PCRX | C | -1.91% | |
| LGND | C | -1.77% | |
| ANIP | F | -1.54% | |
| COLL | F | -1.48% | |
| OCUL | D | -1.44% | |
| AMRX | C | -1.33% | |
| MNMD | C | -1.23% | |
| HRMY | D | -1.22% | |
| WVE | C | -1.17% | |
| HROW | D | -1.17% | |
| INVA | D | -0.98% | |
| EYPT | D | -0.94% | |
| LQDA | F | -0.89% | |
| PLRX | D | -0.87% | |
| FULC | F | -0.85% | |
| ELVN | D | -0.64% | |
| NUVB | C | -0.6% | |
| EOLS | D | -0.52% | |
| PHAT | F | -0.48% | |
| XERS | C | -0.46% |
PCIG: Top Represented Industries & Keywords
XPH: Top Represented Industries & Keywords
Compare ETFs
